Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Knowing what to include in a retirement plan at 50 is key to success. Prepare a robust financial strategy for your future.
21,417 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
The U.S. economy posted 2.2% growth for 2025, a modest slowdown from 2024, with late-year softness in Q4. Consumers a...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
A Friday Supreme Court ruling spurs new tariffs, forcing small business owners scramble to cope as costs rise and cas...
U.S. equities drift as tariff uncertainty lingers, with the S&P 500 and SPY easing while investors await policy clari...
A new AI-powered marketing platform is offering shares at $0.85 in a Reg A+ round, drawing comparisons to early Nvidi...
In 2026, Ramsey’s no credit score concept draws fresh scrutiny as lenders balance underwriting rules with consumer ac...
A looming court decision and budget pressures place the consumer financial protection bureau at a crossroads, with co...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
A widely followed crypto trader called Cardano ADA one of his worst investments, igniting a cross-community debate ab...
Investors watch the moves of billionaires to learn how they navigate risk and opportunity. This piece breaks down how...